The story of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, yielding billions in income, its patent expiration created a flood of generic competition , significantly diminishing its position . While certain businesses may try to capitalize on related treatments , the current landscap